CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Revenue Growth by Quarter and Year

Kempharm Inc's Revenue results by quarter and year




KMPH Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 2.58 2.37 1.38
III Quarter September 2.87 1.97 1.93 11.46
II Quarter June 1.30 11.99 6.91 0.00
I Quarter March 3.97 12.12 2.09 0.00
FY   8.14 28.66 13.30 12.84



KMPH Revenue third quarter 2022 Y/Y Growth Comment
Kempharm Inc reported Revenue rise of 45.89% year on year in the third quarter 2022, to $ 2.87 millions, this is lower than Kempharm Inc's recent average Revenue rise of 49.26%.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 67 other companies have achieved higher Revenue growth. While Kempharm Inc' s Revenue jump of 45.89% ranks overall at the positon no. 537 in the third quarter 2022.




KMPH Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 8.86 % 71.74 % -
III Quarter September 45.89 % 2.07 % -83.16 % -
II Quarter June -89.16 % 73.52 % - -
I Quarter March -67.24 % 479.9 % - -
FY   - 115.49 % 3.58 % -

Financial Statements
Kempharm Inc's third quarter 2022 Revenue $ 2.87 millions KMPH's Income Statement
Kempharm Inc's third quarter 2021 Revenue $ 1.97 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Revenue Growth >>


KMPH Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 30.96 % 22.8 % -87.96 %
III Quarter September 121.08 % -83.57 % -72.07 % -
II Quarter June -67.25 % -1.07 % 230.62 % -
I Quarter March 53.88 % 411.39 % 51.45 % -
FY (Year on Year)   - 115.49 % 3.58 % -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #68
Healthcare Sector #132
Overall #537

Revenue Y/Y Growth Statistics
High Average Low
480.04 % 49.26 % -89.15 %
(Mar 31 2021)   (Jun 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #68
Healthcare Sector #132
Overall #537
Revenue Y/Y Growth Statistics
High Average Low
480.04 % 49.26 % -89.15 %
(Mar 31 2021)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kempharm Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
412.13 % 50.96 % -88 %
(Mar 31 2021)  


KMPH's III. Quarter Q/Q Revenue Comment
Kempharm Inc achieved in the III. Quarter 2022 above company average sequential Revenue doubling of 121.08%, to $ 2.87 millions, from $1.30 millions in the second quarter.
Kempharm Inc is undergoing a remarkable growth, not only recording better then regular growth, but also increasing speed.

Within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Kempharm Inc's Revenue growth quarter on quarter, overall rank is 93.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #25
Healthcare Sector #37
Overall #93
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #25
Healthcare Sector #37
Overall #93
Revenue Q/Q Growth Statistics
High Average Low
412.13 % 50.96 % -88 %
(Mar 31 2021)  


KMPH's III. Quarter Q/Q Revenue Comment
Kempharm Inc achieved in the III. Quarter 2022 above company average sequential Revenue doubling of 121.08%, to $ 2.87 millions, from $1.30 millions in the second quarter.
Kempharm Inc is undergoing a remarkable growth, with claiming higher then regular gain, and additionally accelerating rate.

Within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Kempharm Inc's Revenue growth quarter on quarter, overall rank is 93.


Kempharm Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 10.72 $ 9.81 $ 20.50 $ 28.65 $ 28.43
Y / Y Revenue Growth (TTM) -62.3 % -65.44 % -12.09 % 115.61 % 131.21 %
Year on Year Revenue Growth Overall Ranking # 2462 # 2985 # 2656 # 217 # 241
Seqeuential Revenue Change (TTM) 9.26 % -52.13 % -28.45 % 0.76 % 0.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 470 # 3981 # 3065 # 2456 # 2913




Cumulative Revenue growth Comment
Kempharm Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Kempharm Inc's annual Revenue improvement would be -62.3% year on year to $11 millions.

In the Healthcare sector 386 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2462, from total ranking in previous quarter at 2985.

Revenue TTM Q/Q Growth Statistics
High Average Low
75.47 %
-0.98 %
-52.13 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 50
Healthcare Sector # 387
Overall # 2462

Revenue TTM Y/Y Growth Statistics
High Average Low
131.21 %
22.84 %
-65.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 50
Sector # 112
S&P 500 # 470
Cumulative Revenue growth Comment
Kempharm Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Kempharm Inc's annual Revenue drop would be -62.3% year on year to $11 millions.

In the Healthcare sector 386 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2462, from total ranking in previous quarter at 2985.

Revenue TTM Q/Q Growth Statistics
High Average Low
75.47 %
-0.98 %
-52.13 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 50
Healthcare Sector # 387
Overall # 2462

Revenue TTM Y/Y Growth Statistics
High Average Low
131.21 %
22.84 %
-65.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 50
Sector # 112
S&P 500 # 470




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KMPH's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for KMPH's Competitors
Revenue Growth for Kempharm Inc's Suppliers
Revenue Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Immunitybio inc 78.79%$ 78.788 millions
Sintx Technologies Inc 78.24%$ 78.243 millions
Molecular Templates Inc 78.23%$ 78.226 millions
Arbutus Biopharma Corp78.20%$ 78.204 millions
Icu Medical Inc77.90%$ 77.902 millions
Inspire Medical Systems inc 77.01%$ 77.009 millions
Pulmatrix Inc 75.12%$ 75.117 millions
Delcath Systems Inc 73.56%$ 73.563 millions
1life Healthcare Inc 72.71%$ 72.711 millions
Ikena Oncology Inc 70.90%$ 70.902 millions
Biodesix Inc 70.07%$ 70.066 millions
Greenlight Biosciences Holdings Pbc68.65%$ 68.647 millions
Dariohealth Corp 68.37%$ 68.366 millions
Progyny Inc 67.95%$ 67.946 millions
Immunogen inc 66.94%$ 66.938 millions
Infinity Pharmaceuticals Inc 66.36%$ 66.355 millions
Checkpoint Therapeutics inc 65.52%$ 65.517 millions
Applied Uv Inc 65.44%$ 65.437 millions
Eagle Pharmaceuticals inc 65.36%$ 65.360 millions
Ethema Health Corporation 64.46%$ 64.461 millions
Sensus Healthcare Inc 63.08%$ 63.077 millions
Catalyst Pharmaceuticals Inc 59.21%$ 59.215 millions
Mymetics Corporation58.54%$ 58.537 millions
Clene Inc 58.18%$ 58.182 millions
Dbv Technologies S a 56.76%$ 56.765 millions
Ptc Therapeutics inc 56.50%$ 56.496 millions
Janux Therapeutics Inc 56.43%$ 56.428 millions
Dynavax Technologies Corporation56.37%$ 56.367 millions
Bionano Genomics Inc 55.12%$ 55.124 millions
Deciphera Pharmaceuticals Inc 54.93%$ 54.927 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OHPA's Profile

Stock Price

OHPA's Financials

Business Description

Fundamentals

Charts & Quotes

OHPA's News

Suppliers

OHPA's Competitors

Customers & Markets

Economic Indicators

OHPA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071